Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 1356856)

Published in Ann Surg on January 01, 2005

Authors

Hauke Lang1, Georgios C Sotiropoulos, Nils R Frühauf, Marco Dömland, Andreas Paul, Eva-Maria Kind, Massimo Malagó, Christoph E Broelsch

Author Affiliations

1: Department of General Surgery and Transplantation, University Hospital Essen, Hufelandstr. 55, D-45122 Essen, Germany. hauke.lang@uni-essen.de

Associated clinical trials:

Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS) (LAPS) | NCT02184182

Articles citing this

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg (2008) 1.65

Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today (2011) 1.29

Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc (2006) 1.28

AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol (2007) 1.10

Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg (2007) 1.05

Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol (2007) 1.03

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00

Photodynamic therapy for unresectable cholangiocarcinoma. Dig Dis Sci (2011) 1.00

Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma. Ann Surg Oncol (2012) 0.97

Liver metastasis with intraductal invasion originating from rectal cancer: report of a case. Surg Today (2008) 0.94

Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2008) 0.90

Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford) (2008) 0.89

Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88

GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma. Neoplasia (2007) 0.87

Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87

Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma. Can J Gastroenterol (2011) 0.82

Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) (2014) 0.81

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial. Trials (2014) 0.80

Role of laparoscopic ultrasound during diagnostic laparoscopy for proximal biliary cancers: a single series of 100 patients. Surg Endosc (2015) 0.79

Criteria of unresectability and the decision-making process. HPB (Oxford) (2008) 0.78

Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma. Drug Des Devel Ther (2014) 0.78

Late recurrence after resection of mass-forming intrahepatic cholangiocarcinoma: report of a case. Surg Today (2012) 0.77

A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma. Am J Cancer Res (2015) 0.77

A comparative evaluation of ablations produced by high-frequency coagulation-, argon plasma coagulation-, and cryotherapy devices in porcine liver. Int J Colorectal Dis (2012) 0.77

R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci (2008) 0.75

Low rate of active treatment of patients with hilar cholangiocarcinoma. Ann R Coll Surg Engl (2013) 0.75

Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. J Gastroenterol (2006) 0.75

Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study. World J Surg Oncol (2015) 0.75

Intensity-modulated radiotherapy following null-margin resection is associated with improved survival in the treatment of intrahepatic cholangiocarcinoma. J Gastrointest Oncol (2015) 0.75

What we learned from difficult hepatectomies in patients with advanced hepatic malignancy. Korean J Hepatobiliary Pancreat Surg (2011) 0.75

Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma. JAMA Surg (2017) 0.75

Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy. J Gastroenterol (2012) 0.75

Articles cited by this

Biliary tract cancers. N Engl J Med (1999) 6.36

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (2001) 5.12

Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg (1994) 2.98

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg (2002) 2.62

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16

Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer (2002) 1.85

Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72

Surgical treatment of cholangiocellular carcinoma. World J Surg (1995) 1.47

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35

Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (2000) 1.25

Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg (1998) 1.24

Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery (1992) 1.23

Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet (2000) 1.22

Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.20

Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20

Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11

Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11

Surgical treatment of cholangiocarcinoma. Hepatogastroenterology (1997) 1.09

Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06

Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg (2002) 1.05

Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg (1998) 1.03

Improved staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol (1997) 1.02

A western surgical experience of peripheral cholangiocarcinoma. Br J Surg (1996) 0.99

Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg (2002) 0.98

Extended left hepatectomy: technical aspects of an evolving procedure. Br J Surg (1993) 0.98

Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg (1995) 0.93

Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg (1999) 0.90

Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol (2002) 0.86

Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg (1998) 0.85

Articles by these authors

Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2009) 5.26

Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86

"Hepar divisum"--as a rare donor complication after intraoperative mortality of the recipient of an intended living donor liver transplantation. Liver Transpl (2006) 2.81

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol (2010) 2.71

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology (2010) 2.60

Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int (2011) 2.25

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab (2006) 2.10

The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats. J Surg Oncol (2012) 2.03

One or 4 h of "in-house" reconditioning by machine perfusion after cold storage improve reperfusion parameters in porcine kidneys. Transpl Int (2014) 2.00

Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99

Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int (2008) 1.95

The White test: a new dye test for intraoperative detection of bile leakage during major liver resection. Arch Surg (2008) 1.86

Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79

Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg (2005) 1.69

Living-related liver transplantation from the view of the donor: a 1-year follow-up survey. Transplantation (2002) 1.66

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid (2004) 1.62

Endoscopic therapy of posttransplant biliary stenoses after right-sided adult living donor liver transplantation. Clin Gastroenterol Hepatol (2005) 1.58

Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant (2008) 1.56

Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56

Evaluation of living liver donors with an all-inclusive 3D multi-detector row CT protocol. Radiology (2006) 1.55

Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept. Transplantation (2016) 1.54

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer (2010) 1.51

Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Transplantation (2007) 1.51

Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47

Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46

Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. BMC Cancer (2008) 1.44

Blood-transfusion requirements and blood salvage in donors undergoing right hepatectomy for living related liver transplantation. Anesth Analg (2003) 1.44

Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. Transplantation (2015) 1.44

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

Lipid peroxidation products in machine perfusion of older donor kidneys. J Surg Res (2012) 1.42

Acute hepatic failure in swine: hepatectomy versus vascular occlusion. J Invest Surg (2004) 1.42

Does PEEP impair the hepatic outflow in patients following liver transplantation? Intensive Care Med (2006) 1.41

Outcome after kidney transplantation in children with thrombotic risk factors. Pediatr Transplant (2006) 1.39

Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation. Pediatr Transplant (2006) 1.39

Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg (2003) 1.31

Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl (2006) 1.30

Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology (2005) 1.27

Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2012) 1.26

Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg (2005) 1.25

Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg (2009) 1.25

VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res (2007) 1.24

Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl (2004) 1.22

Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology (2010) 1.22

Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl (2006) 1.22

Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21

Major bile duct injuries after laparoscopic cholecystectomy: a tertiary center experience. J Gastrointest Surg (2004) 1.21

Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl (2006) 1.20

The ALPPS procedure for extended indications in liver surgery: an old finding applied in surgical oncology. Ann Surg (2013) 1.19

Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: is there any evidence-based information? Thyroid (2008) 1.19

Laparoscopic inguinal hernia repair as a potential complicating factor in kidney transplantation. Transplantation (2005) 1.17

Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg (2010) 1.17

Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery (2010) 1.15

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts. Clin Cancer Res (2003) 1.14

Surgical treatment of nonparasitic cysts of the liver: open versus laparoscopic treatment. Am J Surg (2009) 1.14

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab (2005) 1.14

A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg (2014) 1.11

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg (2010) 1.09

Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol (2008) 1.08

The effect of education on the attitude of medical students towards organ donation. Ann Transplant (2012) 1.06

A Question Seeking for an Answer: Use of T-tube in the Era of Liver Transplantation With Grafts From Extended Criteria Donors and Donors After Cardiac Death. Ann Surg (2015) 1.05

Computer-assisted surgery planning for complex liver resections: when is it helpful? A single-center experience over an 8-year period. Ann Surg (2010) 1.04

Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival. Thyroid (2008) 1.04

Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci (2008) 1.03

The role of surgery in Caroli's disease. J Am Coll Surg (2006) 1.03

AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases. Liver Int (2011) 1.03